Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia caused by Pseudomonas aeruginosa: a multicenter, randomized clinical trial (SHORTEN-2) with a DOOR/RADAR analysis
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: PUBLIC ANDALUSIAN FOUNDATION FOR THE MANAGEMENT OF HEALTH RESEARCH IN SEVILLE
- Phase: IV
- Execution start: 24/01/2022
- End of execution: 30/05/2025
- IP: MIGUEL ANGEL LOPEZ ZUÑIGA